Source: BIOSPACE

Auxilium: Auxilium Pharmaceuticals Announces Fundamental Change And Make-Whole Fundamental Change Relating To Outstanding Convertible Senior Notes

CHESTERBROOK, Pa., Feb. 3, 2015 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. ("Auxilium") today announced that it has delivered a notice to holders of its 1.50% convertible senior notes due 2018 (the "Notes"), pursuant to the indenture governing the Notes (as supplemented, the "Indenture"), notifying holders...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
500-1.0K
Adrian Adams's photo - President & CEO of Auxilium Pharmaceuticals Inc

President & CEO

Adrian Adams

CEO Approval Rating

69/100

Read more